ESP: A Method To Predict Toxicity and Pharmacological Properties of Chemicals Using Multiple MCASE Databases
暂无分享,去创建一个
Hao Zhu | Gilles Klopman | Julian M. Ivanov | Suman K. Chakravarti | Roustem D. Saiakhov | G. Klopman | J. Ivanov | S. Chakravarti | R. Saiakhov | Hao Zhu
[1] J. Contrera,et al. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. , 1998, Regulatory toxicology and pharmacology : RTP.
[2] H. Rosenkranz,et al. Prediction of the carcinogenicity of a second group of organic chemicals undergoing carcinogenicity testing. , 1996, Environmental health perspectives.
[3] G. Klopman. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules , 1985 .
[4] B. Ames,et al. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. , 1975, Mutation research.
[5] H S Rosenkranz,et al. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE. , 1994, Mutation research.
[6] B. Ames,et al. A new Salmonella tester strain, TA97, for the detection of frameshift mutagens. A run of cytosines as a mutational hot-spot. , 1982, Mutation research.
[7] G Klopman,et al. In-Silico Screening of High Production Volume Chemicals for Mutagenicity using the mcase QSAR Expert System , 2003, SAR and QSAR in environmental research.
[8] George M. Whitesides,et al. FEED-FORWARD NEURAL NETWORKS IN CHEMISTRY : MATHEMATICAL SYSTEMS FOR CLASSIFICATION AND PATTERN RECOGNITION , 1993 .
[9] G. Klopman. MULTICASE 1. A Hierarchical Computer Automated Structure Evaluation Program , 1992 .
[10] Mark A. Murcko,et al. Virtual screening : an overview , 1998 .
[11] R Benigni,et al. QSARS of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals. , 1996, Mutation research.
[12] Gilles Klopman,et al. Structure-activity relationship study of a diverse set of estrogen receptor ligands (I) using MultiCASE expert system. , 2003, Chemosphere.
[13] K. Enslein,et al. Use of SAR in computer-assited prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program , 1994 .
[14] H S Rosenkranz,et al. Structure-activity and mechanistic relationships: the effect of chemical overlap on structural overlap in data bases of varying size and composition. , 1996, Mutation research.
[15] Y T Woo,et al. Development of structure-activity relationship rules for predicting carcinogenic potential of chemicals. , 1995, Toxicology letters.
[16] E Zeiger,et al. Chemicals mutagenic in Salmonella typhimurium strain TA1535 but not in TA100. , 1998, Mutation research.
[17] Corwin Hansch,et al. On the Parametrization of the Toxicity of Organic Chemicals to Tetrahymena pyriformis. The Problem of Establishing a Uniform Activity , 2002, J. Chem. Inf. Comput. Sci..
[18] M Karplus,et al. Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks. , 1996, Journal of medicinal chemistry.
[19] Gilles Klopman,et al. Screening of high production volume chemicals for estrogen receptor binding activity (II) by the MultiCASE expert system. , 2003, Chemosphere.
[20] B. Ames,et al. Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.
[21] D. Sanderson,et al. Computer Prediction of Possible Toxic Action from Chemical Structure; The DEREK System , 1991, Human & experimental toxicology.
[22] G Klopman,et al. Diversity analysis of 14 156 molecules tested by the National Cancer Institute for anti-HIV activity using the quantitative structure-activity relational expert system MCASE. , 1999, Journal of medicinal chemistry.